4th Nov 2009 07:00
Avacta Group plc Notification of Results
Avacta Group plc, the company providing innovative, high value technologies and services to the pharmaceutical and diagnostics markets, will announce its results for the year ended 31 July 2009, on Thursday 26 November.
An analyst presentation will take place at the offices of Daniel Stewart & Company Plc, Becket House, 36 Old Jewry, London EC2R 8DD, on the day and those wishing to attend should contact Kathy Boate at the details below.
4 November 2009Enquiries:Avacta Group plc Tel: 0870 835 4367
Alastair Smith, Chief Executive Officer www.avacta.com
Haggie Financial LLP Tel: 020 7417 8989 Kathy Boate/Nicholas Nelson [email protected] Nominated Adviser: Tel: 020 7776 6550 Daniel Stewart & Company Plc Simon Leathers Novum Securities Limited Tel: 020 7399 9400 Henry Turcan Notes to Editors:About Avacta
Avacta was spun-out from the University of Leeds in 2004 by its current management team as a biophysics company, with the aim of combining the disciplines of physics and biology to develop innovative technologies and expert technical services to address unmet needs in the biopharmaceutical and healthcare sectors. Avacta has a core bio-analytical technology development programme addressing the needs of the biopharmaceutical sector to fully characterise their new products at the earliest stage in their development to reduce the risk of late stage failure. High end analytical instruments and leading edge contract research services are being provided to the biopharmaceutical and healthcare/personal-care materials sectors through the Group's biotech support division, Avacta Analytical. High value solutions for rapid, point of care diagnostics based on these core bio-analytical technologies, with a near term focus on veterinary diagnostics, are being delivered through Avacta Animal Health. Longer term these technologies will be transferred into the human clinical diagnostics market. Avacta listed on AIM in August 2006.
vendorRelated Shares:
Avacta Group